Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.525 USD | 0.00% | -16.02% | +164.35% |
May. 31 | Sector Update: Health Care Stocks Advance Friday Afternoon | MT |
May. 31 | Ocugen Gets Recommendation For Dose Escalation in Eye Disease Trial; Shares Climb | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+164.35% | 392M | |
+49.28% | 56.87B | |
+37.15% | 39.72B | |
-5.96% | 39.27B | |
-6.90% | 28.73B | |
+13.23% | 26.21B | |
-15.86% | 19.79B | |
+32.51% | 12.28B | |
+27.88% | 12.23B | |
+0.73% | 12.12B |
- Stock Market
- Equities
- OCGN Stock
- News Ocugen, Inc.
- Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study